Singapore markets closed

Vertex Pharmaceuticals Incorporated (VX1D.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
373.950.00 (0.00%)
At close: 04:25PM BST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
10,369,100
10,504,000
6,795,000
5,988,200
-
Other short-term investments
849,200
274,500
729,900
670,700
-
Total cash
11,218,300
10,778,500
7,524,900
6,658,900
-
Net receivables
1,563,400
1,442,200
1,136,800
885,400
-
Inventory
738,800
460,600
353,100
280,800
-
Other current assets
84,300
74,400
59,200
79,700
-
Total current assets
14,144,200
13,234,800
9,560,600
8,133,400
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,641,800
2,483,100
2,320,400
2,074,700
-
Accumulated depreciation
-1,188,900
-1,027,300
-896,000
-790,600
-
Net property, plant and equipment
1,452,900
1,455,800
1,424,400
1,284,100
-
Equity and other investments
2,497,800
112,200
-
-
-
Goodwill
1,088,000
1,088,000
1,002,200
1,002,200
-
Intangible assets
839,900
603,600
400,000
400,000
-
Other long-term assets
895,300
409,600
110,800
49,300
-
Total non-current assets
8,586,000
4,916,100
3,871,900
3,618,400
-
Total assets
22,730,200
18,150,900
13,432,500
11,751,800
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
364,900
303,900
195,000
155,100
-
Accrued liabilities
2,318,200
1,788,400
1,266,900
1,135,400
-
Deferred revenues
170,300
159,600
171,700
191,500
-
Other current liabilities
273,200
62,500
16,500
83,500
-
Total current liabilities
3,547,400
2,742,100
2,142,000
1,877,500
-
Non-current liabilities
Deferred revenues
-
-
-
-
88,762
Other long-term liabilities
196,300
233,000
303,300
298,000
-
Total non-current liabilities
1,602,400
1,496,100
1,190,500
1,187,500
-
Total liabilities
5,149,800
4,238,200
3,332,500
3,065,000
-
Stockholders' equity
Common stock
2,600
2,600
2,500
2,600
-
Retained earnings
10,142,400
6,522,800
3,200,800
858,700
-
Accumulated other comprehensive income
-14,300
800
15,900
-68,500
-
Total stockholders' equity
17,580,400
13,912,700
10,100,000
8,686,800
-
Total liabilities and stockholders' equity
22,730,200
18,150,900
13,432,500
11,751,800
-